Feature | 3-D Printing | March 03, 2017

Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts

Dee Dee Wang, Henry Ford Hospital, 3D printing for cardiology, 3-D

Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.

March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA) occlusion procedures when 3-D imaging was used instead of traditional 2D imaging, the Journal of American College of Cardiology has reported.

When 3-D imaging is used, the procedure also boasts a zero percent complication rate compared to a national average of 16.3 percent rate of serious complications in previous clinical trials using 2-D imaging, according to the study led by led Henry Ford Hospital cardiologist Dee Dee Wang, M.D.  The study was published Nov. 21 online in JACC: Cardiovascular Interventions, a publication of the American College of Cardiology Foundation. It looked at the implantation of a LAA closure device, a procedure that lowers the risk of stroke in patients with atrial fibrillation. 

Wang and the team at the Henry Ford Center for Structural Heart Disease also found 3-D imaging decreased the length of the LAA procedure by 34 minutes, which allows for quicker patient recovery and decreases complications.

“These results show just how impactful advanced 3-D imaging is to medicine,” said Wang, who was recently named medical director of 3-D printing at the Henry Ford Innovation Institute. “The pre-planning results in fewer last-minute decisions, less contrast usage, and less catheter movement inside the heart, thereby minimizing the risk of complications. This is the ultimate in personalizing care for our patients.”

Watch a VIDEO interview with Wang as she discusses her program in "Use of 3-D Printing To Help Guide Structural Heart Interventions."

Transcatheter Occulsion of the LAA

The condition – misfiring by the electrical impulses in the upper chambers of the heart – affects how the heart beats and the flow of blood through the body. Due to the irregular and chaotic rhythm, blood can pool, forming clots in a small pouch of the LAA. That raises the risk of stroke five times higher in people with atrial fibrillation, according to the American Heart Association.  

The most common treatment to reduce stroke risk in patients with atrial fibrillation is blood thinners. Despite the proven efficacy, long-term use of blood thinners is not well-tolerated by some patients and carries a significant risk for bleeding complications.  Researchers say nearly half of atrial fibrillation patients eligible for blood thinners are currently untreated due to tolerance and adherence issues.
Approved by the FDA in 2015, the Watchman device closes off the left atrial appendage, dramatically reducing the risk of stroke and alleviating the need for blood thinners. In about an hour, doctors insert a catheter through a leg vein and into the heart, then open the Watchman device to seal off the left atrial appendage sack. Following the procedure, patients typically need to stay in the hospital for 24 hours. Most patients will be able to discontinue the use of blood thinners after 45 days. 

Key to the procedure is anticipating the twists and turns of the heart to reach the LAA, then choosing the correct size Watchman device to seal the opening.

In the study between May 2015 and February 2016, the Henry Ford Center for Structural Heart Disease team implanted the Watchman in 53 patients. All patients underwent pre-procedural CT imaging of the LAA, followed by intraprocedural echocardiographic characterization and guidance with 2-D and 3-D transesophageal echo (TEE) imaging.

In a previous national study, cardiologists using 2-D imaging to insert the Watchman used an average of two devices (1.8 devices per implantation attempt) as they tried to perfectly match the size of the device and the appendage’s opening. But when the Henry Ford cardiologists used 3-D imaging in this most recent study, they were able to size the Watchman device accurately in nearly 100 percent of the procedures (1.245 devices per implantation attempt).

They Henry Ford team also found that they were able to help more patients qualify for this procedure with 3D imaging than 2D.  By traditional 2-D imaging, 10 of the 53 patients (18.9 percent) would have been turned down inappropriately for a procedure they could have benefitted from due to operator inability to fully visualize their anatomy.

“Using 3D imaging allows the doctor to ‘see’ into the heart,” Wang explains. “This is especially important when planning how to move through the left atrium, anticipating the complexity and size of a left atrial appendage.”

Long-time pioneering cardiologist William W. O’Neill, director of the Center for Structural Heart Disease, said the study reinforces the importance advanced work being done at Henry Ford. 

“We pride ourselves on offering life-saving treatments to patients – some who have been told they have no other options,” O’Neill said. “The 3-D Imaging allows us to do it safer and more efficiently. This study also shows why other centers who are not as experienced as our team should absolutely be using this technology to help patients.”

For more information: www.henryford.com/heart

Related Content

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device
News | Artificial Heart| December 11, 2017
CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life science competition for its...
Videos | Advanced Visualization| December 07, 2017
Dianna Bardo M.D., director of body MR and co-director of the 3-D Innovation Lab at Phoenix Children's Hospital.
Edwards Acquires Harpoon Medical
News | Heart Valve Technology| December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System
News | Robotic Systems| December 06, 2017
December 6, 2017 — French company Robocath, which designs and develops...
New data on the Corvia intra-atrial shunt to treat diastolic heart failure were presented at the recent 2017 American Heart Association (AHA) Scientific Sessions. It was the most popular story in November.

New data on the Corvia intra-atrial shunt to treat diastolic heart failure were presented at the recent 2017 American Heart Association (AHA) Scientific Sessions. It was the most popular story in November.

Feature | December 06, 2017 | Dave Fornell
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magaz
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics| December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Toshiba Medical Rolls Out Interactive Learning Tools for Ultrasound and Vascular Training
News | Ultrasound Imaging| December 04, 2017
Toshiba Medical, a Canon Group company, introduced new educational tools and interactive learning resources to help...
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography| December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Overlay Init